Navigation Links
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Date:3/23/2010

RIDGEFIELD, Conn., March 23 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease (PD), which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.

"In a pivotal trial of patients with advanced Parkinson's disease, MIRAPEX ER not only demonstrated significant symptom improvement, but also increased the number of hours during which people with advanced Parkinson's disease had better mobility," said Anthony Schapira, M.D., head of department and chairman of Clinical Neurosciences Specialties, The Institute of Neurology, University College London, London, UK. "With this approval, MIRAPEX ER may now help early as well as advanced PD patients with its convenient once-daily dosing schedule."  

Study findings showed that patients with advanced PD who were treated with MIRAPEX ER experienced superior symptom relief versus placebo. In addition, MIRAPEX ER demonstrated benefits similar to Mirapex® (pramipexole dihydrochloride) tablets, each versus placebo. Treatment with MIRAPEX ER also resulted in significant reductions of off-time (period of time when symptoms return) versus place
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
2. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
3. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
4. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
5. Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
6. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
7. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
8. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
11. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- A decade-long JDRF-funded study led by the Institute ... Germany , is providing a deeper understanding of ... type 1 diabetes (T1D), highlighting the importance of pre-diabetes ... "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression ... The Journal of the American Medical Association . ...
(Date:6/19/2013)... LARKSPUR, Calif. , June 19, 2013 /PRNewswire/ ... to improve sample standardization and handling in many ... the issuance of new patents by the U.S. ... company,s thermo-conductive products developed to standardize sample handling ... accuracy of results in common laboratory procedures. ...
(Date:6/19/2013)... Md. , June 19, 2013 /PRNewswire/ -- Chindex ... an American healthcare company providing services in ... United Family Healthcare, a network of private hospitals ... opening of its Beijing United Family Rehabilitation Hospital ... projects of the United Family Healthcare ("UFH") network. ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5
... Ind., Nov. 1, 2010 Hill-Rom (NYSE: ... as Senior Vice President and Chief Financial Officer. Guinan ... and will officially join Hill-Rom on December 13, 2010. ... & Johnson, Guinan held a number of senior financial ...
... Romark Laboratories announced that data ... being presented at the 61st Annual Meeting of ... Diseases (AASLD), also known as The Liver Meeting® ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100201/FL47022LOGO) (Logo: ...
Cached Medicine Technology:Hill-Rom Appoints Mark Guinan as Chief Financial Officer 2Romark Announces Data Presented at AASLD Meeting 2010 2Romark Announces Data Presented at AASLD Meeting 2010 3Romark Announces Data Presented at AASLD Meeting 2010 4Romark Announces Data Presented at AASLD Meeting 2010 5
(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 ... Marketing Awards program is this Friday, June 21 ... the campaigns, ongoing programs and innovative people who’ve ... For more information, visit http://www.minonline.com/ima . , ... or individual magazine title is eligible to enter. ...
(Date:6/19/2013)... Kleritec, Inc. announced the addition of ... http://www.kleritec.com . In the recent expansion Kleritec ... packages for pre-school and day care providers. The company ... aid teachers across the United States the ability to ... Included in the art and activities packages is all ...
(Date:6/19/2013)... Chrysler made news recently when it refused ... million Jeeps. The Jeep models in question are the 1993-2004 ... to the NHTSA are vulnerable to fire and explosion in ... are rear-mounted and have been alleged to catch fire or ... Cherokee with 32 rear-end crashes, which resulted in 44 deaths ...
(Date:6/19/2013)... Amber Roberson with the Robert Weaver ... Care Health, LLC and Medcase, LLC, became certified ... new professional development course on the Patient Protection ... course for agents has been approved in all ... credits from the Missouri Department of Insurance. , ...
(Date:6/19/2013)... York (PRWEB) June 19, 2013 As ... pancreatic cancer continue to mount in courts throughout the ... & Drug Administration (FDA) recently held a meeting to ... known as incretin mimetics. According to a June ... data from the makers of Januvia and similar drugs, ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3
... COM , , VANCOUVER, Nov. ... COM) today disclosed that its Chairman and Chief Executive Officer, ... 45,000 common shares from his direct holding of Cardiome stock. ... to have been required to involuntarily sell any shares of ...
... the danger is about the same as using drugs ... News) -- Giving blood transfusions to treat anemia in ... clots, say University of Rochester, N.Y., researchers. , But ... cancer treatment-related anemia, the scientists said, after having analyzed ...
... Antonio Banderas launched his fifth,fragrance, BLUE SEDUCTION FOR ... City alongside cast members from Tony Award(R) Winning Best ... of the Roses, Ballet,Hispanico School of Dance, R. Evolucion ... (See video from PUIG USA at:, ...
... Nov. 28 Streamline Health Solutions,Inc. (Nasdaq: STRM ... quarter of fiscal year 2008 ended October 31, 2008 on ... and webcast to discuss,the results on Monday, December 15, at ... conference call to provide additional time for,completion of the necessary ...
... understanding of the disease generally, researchers say , , FRIDAY, ... people with the rarer, inherited form of Alzheimer,s disease ... understand the biology of the brain disorder. , ... a known genetic mutation causing the rare, early-onset form ...
... With new HIV infections outpacing the,number of people newly ... this World AIDS Day to call for a global commitment ... take place,on December 1st, in Washington, D.C., will be followed ... Given the recent election, the world is hopeful that ...
Cached Medicine News:Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 2Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 3Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Streamline Health Reschedules Q3 Financial Results Release and Conference Call for Monday, December 15, 2008 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Faith and Civil Society Leaders Hold Interfaith Service to Commemorate World AIDS Day 2
... The Magnetom C! system features 270 accessibility ... with the smallest pole diameter available (54 ... of up to four coils, increased patient ... field strength is 0.35 Tesla. , ,The ...
... Quality of Vision and Contrast Sensitivity. ... illumination and glare luminance levels for ... testing with/without glare and background luminance ... ANSI standards. All Light Levels Microprocessor ...
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr...
STERILE VIEW Barrier Sleeves combine superior protection against contaminants with unsurpassed comfort and the convenience of universal sizing....
Medicine Products: